🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to evaluate the safety and tolerabili...
Status
Completed
Location
Prince of Wales Hospital
Start Date
2021-07-29
Trial ID
NCT04811716
Treatments Being Tested
The primary objective of the study is to assess the concentration-time prof...
Status
Completed
Location
Regeneron Research Site
Start Date
2021-08-04
Trial ID
NCT04940364
Treatments Being Tested
This study is researching a clinical treatment combination with two experim...
Status
Active Not Recruiting
Location
The Oncology Institute of Hope & Innovation
Start Date
2022-08-01
Trial ID
NCT05133531
Treatments Being Tested
This program is designed to provide access to pozelimab and cemdisiran and ...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT06028594
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and pharm...
Status
Withdrawn
Location
Clinical Trial Site
Start Date
2017-09-19
Trial ID
NCT03303313
Treatments Being Tested
The primary objective of the study is: To evaluate the effect of pozelimab...
Status
Terminated
Location
Regeneron Research Facility
Start Date
2022-10-06
Trial ID
NCT05131204
Treatments Being Tested
The purpose of this study is to evaluate the effect of cemdisiran on protei...
Status
Terminated
Location
Clinical Trial Site
Start Date
2019-09-30
Trial ID
NCT03841448
Treatments Being Tested
Atypical Hemolytic Uremic Syndrome (aHUS) is a rare, lifethreatening, chron...
Status
Withdrawn
Location
Centro di Ricerche Cliniche per le Malattie Rare " Aldo e Cele Daccò"
Start Date
2021-01
Trial ID
NCT03999840
Treatments Being Tested
This study is researching the experimental drugs called pozelimab and cemdi...
Status
Active Not Recruiting
Location
HonorHealth Neurology 2018
Start Date
2021-12-14
Trial ID
NCT05070858
Treatments Being Tested
To evaluate the efficacy of Pozelimab/Cemdisiran combination therapy in pat...
Status
Recruiting
Location
Austin Neuromuscular Center
Start Date
2024-08-08
Trial ID
NCT06479863
Treatments Being Tested